VeraBank, N.A.
Source: SEC Form 13F · as of Mar 2026VeraBank, N.A. holds 13 biotech & pharma companies tracked by BioSniper, totaling $19.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$19.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 14,935 | $3.7M |
| ABBVAbbVie Inc. | 15,256 | $3.3M |
| LLYELI LILLY & Co | 2,768 | $2.5M |
| ABTABBOTT LABORATORIES | 19,673 | $2.0M |
| AMGNAMGEN INC | 4,858 | $1.7M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 24,269 | $1.3M |
| MRKMerck & Co., Inc. | 10,599 | $1.3M |
| PMPhilip Morris International Inc | 7,322 | $1.2M |
| PFEPFIZER INC | 32,528 | $913K |
| GILDGILEAD SCIENCES, INC. | 3,568 | $497K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,320 | $357K |
| BMYBRISTOL MYERS SQUIBB CO | 4,694 | $285K |
| ZTSZoetis Inc. | 1,989 | $235K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.